Ruth Shah

Head of Bayer Co.Lab Berlin at Bayer

Speaker

Ruth Shah, PhD, is Head of Bayer Co.Lab Berlin, which is part of a global network of state-of-the-art incubators supporting early-stage life science and biotech ventures. With fully equipped labs, shared infrastructure, and access to experts and partners, it helps founders bring their brilliant ideas to life - while reducing operational and financial overhead. A dynamic community, the expertise of pharma, and no strings attached. Bayer Co.Lab Berlin is a brand-new facility strategically located on Bayer Pharmaceuticals’ global HQ campus, offering on-site access to expertise across the value chain in one of Europe’s most innovative cities. In her role, Ruth is responsible for developing the Co.Lab Berlin strategy and community and overseeing operations to further cultivate the biotech innovation ecosystem in Berlin. In July 2025, Ruth was named Top 40 under 40 in Berlin for her leadership driving the economy and innovation in the capital region.

Prior to her current position, Ruth was Director, Strategic Program Lead Gene Editing, where she drove the strategic pathfinding and operational build-up of gene editing activities as a cross-company endeavour between Bayer and AskBio, an AAV gene therapy company, which is a wholly owned and independent subsidiary of Bayer. Ruth has a PhD in Cell and Molecular Biology from the University of Edinburgh.